|Bid||0.1350 x 0|
|Ask||0.1400 x 0|
|Day's Range||0.1350 - 0.1400|
|52 Week Range||0.0900 - 0.2450|
|Beta (5Y Monthly)||0.64|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Investing in stocks inevitably means buying into some companies that perform poorly. But the long term shareholders of...
Doug Janzen has been the CEO of Aequus Pharmaceuticals Inc. (CVE:AQS) since 2014. First, this article will compare CEO...
If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly tough on longer term Aequus Pharmaceuticals Inc. (CVE:AQS) shareholders. So they might be feeling emotional abou...